Search

everythinglearnresearchcommunity

for

Search:↓

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

A woman developed a severe skin reaction after getting a birth control implant.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.